Home/Simergent/Steve J. Lindo

SJ

Steve J. Lindo

Co-Founder & CEO

Therapeutic Areas

Nephrology End-Stage Renal Disease (ESRD)

Simergent Pipeline

Drug	Indication	Phase
Archimedes™ APD System	End-Stage Renal Disease (ESRD) requiring peritoneal dialysis	Development

Leadership Team at Simergent

Rick Pendergraft, Ph.D.

Co-Founder & Chief Technology Officer

Dr. James Sloand, MD, FACP, FASN

Chief Medical Officer

View full Simergent profile